Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism
NCT07530705
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Hypoparathyroidism
Interventions
DRUG:
Single subcutaneous injection
DRUG:
Multiple subcutaneous injection
Sponsor
Peking Union Medical College Hospital